Clinical efficacy of weight loss herbal intervention therapy and lifestyle modifications on obesity and its association with distinct gut microbiome: A randomized double-blind phase 2 study
Open Access
- 22 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14
Abstract
Goals: To assess the efficacy and safety of Chinese Medicine Prescription “W-LHIT” in subjects with simple obesity, and to explore its potential mechanism of action.Methods: Thirty-seven patients aged 18 to 60 from Wei-En hospital (Weifang City, Shandong, China), participated in a double blinded, placebo-controlled study. Subjects were randomly divided into 2 groups, 18 in treatment and 19 in placebo group. The treatment group took the “W-LHIT” capsules for two months, while the control group received placebo capsules. Both groups accepted healthy lifestyle education materials. After a 2-month treatment, the placebo group transferred to open-label treatment after unblinding.Results: 72.22% participants in the treatment group lost more than 5% of their body weight, compared with 36.84% in the placebo group (p < 0.001). Body weight loss and body mass index reduction of the treatment group were also significantly higher than those of the placebo group (p < 0.05). These changes were accompanied by increased abundance of Akkermansia muciniphila and Enterococcus faecium, and decreased abundance of Proteobacteria in gut microbiota. Furthermore, the treatment group also showed improvement in obesity-related comorbidities such as hypertension and elevation of liver enzymes. No serious adverse reactions were found during the study period. Weight did not rebound at a follow-up visit 2 months after treatment.Conclusion: W-LHIT significantly improved body weight and comorbid conditions without obvious adverse reaction or rebound weight gain. These effects were associated with increased abundance of probiotics in gut microbiota. W-LHIT may have a potential for treating obesity in conjunction with healthy lifestyle modifications.Keywords
This publication has 40 references indexed in Scilit:
- Proteobacteria: microbial signature of dysbiosis in gut microbiotaTrends in Biotechnology, 2015
- Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiotaNature Communications, 2015
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2014
- Weight loss herbal intervention therapy (W-LHIT) a non-appetite suppressing natural product controls weight and lowers cholesterol and glucose levels in a murine modelBMC Complementary and Alternative Medicine, 2014
- Richness of human gut microbiome correlates with metabolic markersNature, 2013
- Berberine‐induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological DiseasesPhytotherapy Research, 2011
- Metabolic surgery profoundly influences gut microbial–host metabolic cross-talkGut, 2011
- High-sensitivity C-reactive protein is a marker of obesity and not of polycystic ovary syndrome per seFertility and Sterility, 2010
- Health‐Related Quality of Life and Weight Loss among Overweight and Obese U.S. Adults, 2001 to 2002Obesity, 2006
- Secular trends in desired weight of adultsInternational Journal of Obesity, 2006